RecruitingPHASE1, PHASE2NCT04225611
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Intervention
- Dexamethasone(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2021 – 2027
Study locations (1)
- MEEI, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04225611 on ClinicalTrials.gov